Bristol-Myers Squibb Co (BMY): What Is Good About Stock?
Bristol-Myers Squibb Co (NYSE:BMY) has a beta value of 0.38 and has seen 1.56 million shares traded in the recent trading session. The company, currently
Bristol-Myers Squibb Co (NYSE:BMY) has a beta value of 0.38 and has seen 1.56 million shares traded in the recent trading session. The company, currently
In today’s recent session, 2.32 million shares of the Bristol-Myers Squibb Co (NYSE:BMY) have been traded, and its beta is 0.39. Most recently the company’s
In the last trading session, 9.35 million Bristol-Myers Squibb Co (NYSE:BMY) shares changed hands as the company’s beta touched 0.39. With the company’s per share
In last trading session, Bristol-Myers Squibb Co (NYSE:BMY) saw 12.73 million shares changing hands with its beta currently measuring 0.39. Company’s recent per share price
Bristol-Myers Squibb Co (NYSE:BMY) has a beta value of 0.39 and has seen 13.5 million shares traded in the last trading session. The company, currently
During the last session, Bristol-Myers Squibb Co (NYSE:BMY)’s traded shares were 12.42 million, with the beta value of the company hitting 0.37. At the end
Bristol-Myers Squibb Co (NYSE:BMY)’s traded shares stood at 11.95 million during the last session, with the company’s beta value hitting 0.38. At the close of
In the latest trading session,, 1.78 million Bristol-Myers Squibb Co (NYSE:BMY) shares changed hands as the company’s beta touched 0.37. With the company’s most recent
Bristol-Myers Squibb Co (NYSE:BMY) has a beta value of 0.38 and has seen 2.33 million shares traded in the recent trading session. The company, currently
© 2024, Powered by Smart TechOne